参麦注射液协同阿托品多巴胺对合并急性右室心肌梗死患者缓慢心律失常及低血压的治疗作用

[目的]探讨参麦注射液对急性心肌梗死合并右室梗死患者缓慢心律失常及低血压的治疗作用。[方法]选择符合急性心肌梗死合并右室梗死诊断标准的住院患者75例 ,其中合并缓慢心律失常的患者58例 ,随机分为治疗组 (加用参麦注射液 )和对照组 (未使用参麦注射液 ) ,比较两组使用阿托品的平均剂量 ;其中合并低血压的住院患者41例。随机分为治疗组(多巴胺 参麦注射液 )和对照组 (多巴胺) ,比较两组使用多巴胺持续时间及使用的最大浓度。[结果]治疗组与对照组相比 ,使用参麦注射液可显著提高缓慢心律失常患者心室率并减少了使用阿托品的剂量 ;在合并低血压患者中 ,使用参麦注射液可缩短多巴胺的维持时间 (P<0.05) ,并使多巴胺的最大使用浓度减低(P<0.05)。[结论]在急性心肌梗死合并右室梗死患者 ,出现缓慢心律失常及 (或)低血压时配合使用参麦注射液可以达到更好的治疗效果

Effect of Shenmai Injection with atropine,dopamine on slow arrhythmia and hypotension in patients with right ventricle infarction

[ObjectiveTo explore the effect of Shenmai Injection on slow arrhythmia and hypotension in patients with right ventricle infarction.[Methods]Seventy-five cases accorded with the criterion were selected.Of them58cases combined with slow arrhythmia were randomly divided into treatment group(with shenmai injection)and control group(without Shenmai injection).The average dosage of atropine was compared.Fourty-one cases combined with hypotension were randomly di-vided into treatment group(Shenmai injection and dopamine)and control group(dopamine).The sustained periods and the maximum concentration of dopamine were compared.[Result]Compared with the control group,Shenmai injection could obviously increase ventricular rate and decrease the dosages of atropine in patients with slow arrhythmia in treatment group.In patients with hypotension,Shenmai injection could shorten the maintenance periods of dopamine(P<0.05),and descend the maximum concentration of dopamine(P<0.05).[Conclusion]Shenmai injection possesses good therapeutic effect on slow arrhythmia and hypotension in patients with right ventricle infarction.